AstraZeneca’s new weight-loss pill, AZD5004, shows promise in early trials with tolerable side effects, advancing to Phase II studies focused on reducing obesity.
AstraZeneca reported on Monday that its experimental weight-loss pill, AZD5004, licensed from China's Eccogene for up to $2 billion, was found safe and tolerable in an early-stage trial.
The study, which included 72 participants who were either healthy or had type 2 diabetes, showed side effects consistent with other GLP-1 drugs, such as nausea and vomiting. Based on these findings, AstraZeneca has advanced AZD5004 to Phase II trials focused on weight reduction in overweight and obese individuals, with completion expected by late 2025.
Unlike injectable treatments from competitors Eli Lilly and Novo Nordisk, AZD5004 is a small molecule pill that can be combined with other medications and taken with or without food, offering potential advantages for patients with additional health conditions.
AstraZeneca also shared early-stage data on other obesity drugs, AZD6234 and AZD9550, which target different hunger-related hormones and will undergo further Phase II testing through 2026.
Meanwhile, Viking Therapeutics released early trial results for its own oral obesity drug, which briefly boosted its stock before a decline.
Russia has violated an energy ceasefire announced by U.S. President Donald Trump, Ukrainian leader Volodymyr Zelen...
Here's your AnewZ Daily Brief for 12 October 2026 with the top five natural disasters happening around the world. ...
One person was killed and nearly a dozen hurt in a new attack Riyadh's international airport on Sunday, Saudi ...
The explosion at King Khalid International Airport in Riyadh on Saturday afternoon killed at least 12 people and injured a further 309, according to Saudi Arabia’s Civil Aviation Authority. The airport remains closed until further notice.
Yemen's Houthis renewed warning to airlines, airport workers, and travellers against using Saudi airports, saying the warning should be taken seriously and that the kingdom “bore responsibility for failed interceptions”, a day after an attack on Riyadh's international airport that killed 12 people.
One person was killed and nearly a dozen hurt in a new attack Riyadh's international airport on Sunday, Saudi authorities reported, a day after a strike claimed by Yemen's Houthis that killed 13 people and wounded more than 300.
The Houthi movement has escalated their attacks on Saudi Arabia, targeting the airport in Riyadh and other cities, killing more than a dozen people.
Ukraine is ready to stop attacks on Russian oil refineries if Moscow also halts strikes on Ukrainian energy infrastructure, President Volodymyr Zelenskyy said on Sunday.
Visitors to Armenia could face temperature screening after a lab worker died from suspected Pneumonic plague in Russia, Yerevan’s Health Minister Anahit Avanesyan told lawmakers on Wednesday, Armenian state news agency Armenpress reported.
Health advice now reaches people through social media, fitness apps, wearable technology and AI. From detoxes and protein-focused diets to skincare and fitness trends, online wellness content is shaping everyday health choices while raising concerns about misinformation and potential risks.
Global cholera deaths reached their highest annual level in more than 20 years in 2025, despite a decline in reported cases, according to the World Health Organization (WHO).
Chinese researchers have developed the world’s smallest CT scanner, a portable device designed to produce images of tiny fossils and archaeological relics.
Here's your AnewZ Daily Brief for 17 September 2026. These are the top five stories making headlines in the field of health.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment